Biopharma investors set plans for expedited ROI by developing products, not companies
29 November 2011
Lee Stirling
Please Login to read the full article.
29 November 2011
Lee Stirling
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Taking aim at cost reductions, Senate panel chief puts bull's-eye on biopharma
- UCB execs take positive stance as big pharma peers wail about difficult environment
- 2012 Scrip 100 Preview: Base jumping for pharma – a slower descent from the patent cliff?
- Stockwatch. Eyeballs or optical delusion?
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
